Dale 123, I think bkkrunner is referring to my post of 18 July referencing the fact that financial incentives are permitted in Australia for clinical trials over and above out of pocket expenses
To save time, below is the text I posted on that day
On the issue of incentive payments for clinical trial recruiting in Australia here is the link to the official relevant government document published in 2019 that covers this matter ( this being the Australian Government National Health and Research Council) https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/NHMRC-Payment-of-participants-in-research.pdf
The relevant clause therein is Clause 1.2 under the heading of Guidance......... QUOTE .. Generally, payment of participants should be limited to reimbursement of documented expenses and remuneration for time and inconvenience in order to minimise the likelihood of a payment acting as an undue influence (or undue inducement). In cases where the research offers little or no benefit to individuals (e.g. early phase clinical trials) or where the research requires the participation of target populations that are difficult to recruit, payment may be offered as an incentive to participation, as long as adequate processes are in place to promote valid consent UNQUOTE The interesting part is what I have highlighted in bold font. Well, we are in an early phase clinical trials and also have found it difficult to recruit so as I read it, based on these criteria as above, we can offer a financial incentive to participants over and above standard reimbursement costs. Personally I would think $20k per person for the 15 targetted participants ... its not a large amount in total in the context of current annual IBX expenditures.So all this blah blah about ethical concerns does not apply as I see it
IBX Price at posting:
6.9¢ Sentiment: Hold Disclosure: Held
